Arrowstreet Capital’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,486
Closed -$37K 1531
2022
Q2
$37K Sell
12,486
-31,502
-72% -$97.7K ﹤0.01% 1202
2022
Q1
$169K Sell
43,988
-102,966
-70% -$428K ﹤0.01% 1127
2021
Q4
$616K Sell
146,954
-48,230
-25% -$205K ﹤0.01% 1254
2021
Q3
$912K Buy
195,184
+48,211
+33% +$237K ﹤0.01% 1323
2021
Q2
$785K Buy
146,973
+26,808
+22% +$140K ﹤0.01% 1599
2021
Q1
$544K Sell
120,165
-289,294
-71% -$1.25M ﹤0.01% 1974
2020
Q4
$1.52M Sell
409,459
-23,300
-5% -$89.4K ﹤0.01% 1698
2020
Q3
$1.53M Buy
432,759
+203,965
+89% +$707K ﹤0.01% 1673
2020
Q2
$709K Buy
228,794
+198,229
+649% +$576K ﹤0.01% 1881
2020
Q1
$97K Buy
+30,565
New +$134K ﹤0.01% 1789
2018
Q3
Sell
-65,634
Closed -$623K 1376
2018
Q2
$623K Sell
65,634
-418,557
-86% -$4.01M ﹤0.01% 877
2018
Q1
$4.94M Sell
484,191
-115,240
-19% -$1.18M 0.01% 579
2017
Q4
$5.96M Buy
599,431
+269,125
+81% +$2.94M 0.01% 566
2017
Q3
$3.67M Buy
330,306
+278,305
+535% +$3.26M 0.01% 554
2017
Q2
$493K Buy
+52,001
New +$415K ﹤0.01% 881
2015
Q3
Sell
-184,326
Closed -$1.14M 1580
2015
Q2
$1.14M Buy
+184,326
New +$1.13M 0.01% 792

Other funds holding CO

Arrowstreet Capital's CO Position: Q3 2022 in Review

Arrowstreet Capital sold out of Global Cord Blood Corporation (CO) in Q3 2022, closing a stake of 12,486 shares — an estimated $37K sold.

Arrowstreet Capital first reported a position in CO in Q2 2015 and held it in 16 quarters. The position peaked at $5.96M in Q4 2017. 24 funds tracked by Wall St. Rank hold CO as of Q3 2022.

  • Arrowstreet Capital reported no remaining Global Cord Blood Corporation position as of Q3 2022 after selling out during the quarter.
  • Arrowstreet Capital sold 12,486 Global Cord Blood Corporation shares in Q3 2022, an estimated $37K.
  • Arrowstreet Capital first reported a position in Global Cord Blood Corporation in Q2 2015 and held it in 16 quarters.
  • Arrowstreet Capital's Global Cord Blood Corporation position peaked at $5.96M in Q4 2017.
  • 24 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2022.

Based on Arrowstreet Capital's 13F filing for Q3 2022, filed 14 Nov 2022.